PL2277546T3 - Trwały, gotowy do użycia preparat paracetamolu do iniekcji - Google Patents

Trwały, gotowy do użycia preparat paracetamolu do iniekcji

Info

Publication number
PL2277546T3
PL2277546T3 PL09009569T PL09009569T PL2277546T3 PL 2277546 T3 PL2277546 T3 PL 2277546T3 PL 09009569 T PL09009569 T PL 09009569T PL 09009569 T PL09009569 T PL 09009569T PL 2277546 T3 PL2277546 T3 PL 2277546T3
Authority
PL
Poland
Prior art keywords
use injectable
stable ready
paracetamol formulation
injectable paracetamol
formulation
Prior art date
Application number
PL09009569T
Other languages
English (en)
Inventor
Ioulia Tseti
Original Assignee
Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A
Ioulia Tseti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A, Ioulia Tseti filed Critical Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A
Publication of PL2277546T3 publication Critical patent/PL2277546T3/pl

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL09009569T 2009-07-23 2009-07-23 Trwały, gotowy do użycia preparat paracetamolu do iniekcji PL2277546T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09009569.6A EP2277546B1 (en) 2009-07-23 2009-07-23 Stable ready to use injectable paracetamol formulation

Publications (1)

Publication Number Publication Date
PL2277546T3 true PL2277546T3 (pl) 2015-10-30

Family

ID=41264251

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09009569T PL2277546T3 (pl) 2009-07-23 2009-07-23 Trwały, gotowy do użycia preparat paracetamolu do iniekcji

Country Status (10)

Country Link
EP (1) EP2277546B1 (pl)
CY (1) CY1116746T1 (pl)
DK (1) DK2277546T3 (pl)
ES (1) ES2545484T3 (pl)
HR (1) HRP20150815T1 (pl)
HU (1) HUE027032T2 (pl)
PL (1) PL2277546T3 (pl)
PT (1) PT2277546E (pl)
SI (1) SI2277546T1 (pl)
SM (1) SMT201500192B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ZA201300398B (en) * 2012-11-27 2013-09-25 Genfarma Laboratories S L Injectable liquid formulation of the combination of tramadol and paracetamol
JP7181185B2 (ja) * 2016-09-16 2022-11-30 サイデックス・ファーマシューティカルズ・インコーポレイテッド アセトアミノフェンおよびスルホアルキルエーテルシクロデキストリンを含む製剤
GR1010637B (el) * 2023-01-13 2024-02-15 Ιουλια Κλεωνος Τσετη Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση
CN121285367A (zh) 2023-06-02 2026-01-06 尤利亚·采蒂 包含布洛芬的药物组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US20050203175A1 (en) * 2001-12-18 2005-09-15 Ioulia Tseti Parenteral composition of paracetamol
CN1232539C (zh) * 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
US20100004171A1 (en) * 2006-08-08 2010-01-07 Bazan Nicolas G Therapeutic Methods for Neuropathic Pain
CA2705733C (en) * 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen

Also Published As

Publication number Publication date
CY1116746T1 (el) 2017-03-15
HRP20150815T1 (hr) 2015-09-11
DK2277546T3 (en) 2015-08-17
SI2277546T1 (sl) 2015-09-30
SMT201500192B (it) 2015-09-07
EP2277546B1 (en) 2015-07-15
HK1153400A1 (en) 2012-03-30
PT2277546E (pt) 2015-09-25
EP2277546A1 (en) 2011-01-26
HUE027032T2 (en) 2016-08-29
ES2545484T3 (es) 2015-09-11

Similar Documents

Publication Publication Date Title
PT2616064T (pt) Formulações de cetorolac prontas para utilização
DK2387989T3 (da) Langtidsvirkende formuleringer med insuliner
IL245326B (en) pharmaceutical preparation
EP2646468A4 (en) ANTI-NGF COMPOSITIONS AND THEIR USE
EP2718317A4 (en) GLUCOSE-DEPENDENT INSULINOTROPE POLYPEPTIDE ANALOGUE, PHARMACEUTICAL COMPOSITIONS AND THEIR USE
ZA201208605B (en) Stable ready to use injectable paracetamol formulation
GB201010193D0 (en) Medicinal use
PT2619182T (pt) Composição farmacêutica
IL225457A0 (en) Pharmaceutical composition
ZA201208726B (en) High-temperature stable oxygen-carrier-containing pharmaceutical composition
IL221857A (en) Liquid formulations are stabilized
AU332760S (en) Spatula head
PT2579858E (pt) Composição farmacêutica que contém ivabradina
EP2599484A4 (en) INJECTABLE PHARMACEUTICAL PREPARATION OF MELPHALANE
GB201010453D0 (en) Pharmaceutical composition
ZA201206589B (en) Incotine containing formulation
IL239049A0 (en) Dimeric compounds containing oxazolidinone, preparations, methods for their preparation and their use
IL215265A0 (en) Syringe for single use
SI2277546T1 (sl) Stabilen pripravljen za uporabo injekcijski sestavek paracetamola
IL206739A0 (en) Injectable pharmaceutical composition
IL221501A (en) Medicinal product containing miramistine
GB201001911D0 (en) Pharmaceutical composition
EP2536688A4 (en) STABLE DOSAGE FORMS OF LEVOMILNACIPRAN
ZA201300098B (en) Pharmaceutical composition with enhanced solubility characteristics
GB201010242D0 (en) Single use disposable feet protectors with advertising purpose for external use